CE
CEVE.US Ceres Ventures Inc
- Market cap
- USD 8.55K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2012.
Is CEVE.US undervalued?
Graham numberThe Graham number of Ceres Ventures Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ceres Ventures Inc fundamental analysis
No fundamental analysis for Ceres Ventures Inc yet.
Ceres Ventures Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ceres Ventures Inc
Ceres Ventures, Inc. does not have significant operations. Previously, it was research, development, and commercialization of clean technologies for the remediation of polluted water, soil, and air The company was formerly known as PhytoMedical Technologies, Inc. and changed its name to Ceres Ventures, Inc. in November 2011. Ceres Ventures, Inc. was incorporated in 2001 and is based in New York, New York.
Full company profileCeres Ventures Inc financial statements
2012 annualized: Fiscal year 2012 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2012, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ceres Ventures Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -180K | -290K | -687K | -4.26M | -3.87M | -2.19M | -1.50M | -588K | 2.12M | -571K | -411K |
| EBITDA | -180K | -290K | -687K | -4.26M | -3.86M | -2.18M | -1.48M | -588K | 2.14M | -571K | -411K |
| Net Income | 79.5K | -290K | -686K | -4.26M | -3.85M | -2.16M | -1.56M | -694K | 2.03M | -572K | -451K |
| EPS | 0.03 | -0.09 | -0.21 | -1.23 | -1.03 | -0.56 | -0.39 | -0.17 | 0.30 | -0.01 | -0.01 |
| Balance Sheet | |||||||||||
| Total Assets | 139K | 97.6K | 338K | 82.7K | 421K | 2.46M | 683K | 90.6K | 80.9K | 165K | 80.5K |
| Total Liabilities | 54.2K | 86.5K | 921K | 2.02M | 1.60M | 1.24M | 1.02M | 1.08M | 193K | 559K | 486K |
| Shareholders' Equity | 84.5K | 11.1K | -583K | -1.94M | -1.18M | 1.21M | -334K | -986K | -112K | -394K | -405K |
| Cash & Short-term Investments | 139K | 97.6K | 338K | 63.8K | 386K | 2.43M | 666K | 75.3K | 44.6K | 114K | 4.81K |
| Total Debt | - | - | 1.65M | 1.70M | 1.21M | 1.00M | 750K | 750K | 6.89K | 112K | 200K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -33.8K | -41.1K | -676K | -2.12M | -2.33M | -1.07M | -1.50M | -591K | -441K | -223K | -138K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 20.5K | 21.4K | 3.75K | 21.2K | 0.00 | 0.00 | 37.1K | 30.3K |
| Free Cash Flow | -33.8K | -41.1K | -676K | -2.14M | -2.35M | -1.08M | -1.52M | -591K | -441K | -260K | -168K |
| Ratios | |||||||||||
| ROE | 94.1% | -2,601.8% | - | - | - | -177.5% | - | - | - | - | - |
| ROA | 57.3% | -297.0% | -203.2% | -5,150.6% | -915.5% | -87.7% | -228.5% | -766.3% | 2,505.9% | -346.7% | -560.1% |
| Debt to Equity | - | - | - | - | - | 0.82x | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ceres Ventures Inc dividends
Ceres Ventures Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:50 on Dec 12, 2011.
Who owns Ceres Ventures Inc
Ownership data of Ceres Ventures Inc is not available yet.
Ceres Ventures Inc company profile
- Company name
- Ceres Ventures Inc
- Ticker
- CEVE.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Fiscal year end
- December
- Address
- 430 Park Avenue, New York, NY, United States, 10022
- Phone
- 800-611-3388
- Website
- -
About Ceres Ventures Inc
Ceres Ventures, Inc. does not have significant operations. Previously, it was research, development, and commercialization of clean technologies for the remediation of polluted water, soil, and air The company was formerly known as PhytoMedical Technologies, Inc. and changed its name to Ceres Ventures, Inc. in November 2011. Ceres Ventures, Inc. was incorporated in 2001 and is based in New York, New York.
Ceres Ventures Inc management
1- Mr. Frank J. FabioInterim Chief Financial Officer